VITASPRING BIOMEDICAL CO., LTD.: net property, plant and equipment
Net property, plant and equipment for VITASPRING BIOMEDICAL CO., LTD. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All VITASPRING BIOMEDICAL CO., LTD. financial histories
What this measure means
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
Exact concept: us-gaap:PropertyPlantAndEquipmentNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2017-01-31 to 2026-01-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2026-01-31 | 4,149 | USD | 2026-06-17 | 10-K · 0001640334-26-001082 |
| At date | 2025-01-31 | 14,106 | USD | 2026-06-17 | 10-K · 0001640334-26-001082 |
| At date | 2024-01-31 | 24,063 | USD | 2026-06-08 | 10-K · 0001640334-26-001019 |
| At date | 2023-01-31 | 49,574 | USD | 2026-03-12 | 10-K · 0001640334-26-000426 |
| At date | 2022-01-31 | 64,636 | USD | 2025-12-01 | 10-K · 0001640334-25-002237 |
| At date | 2019-01-31 | 1,424 | USD | 2019-04-26 | 10-K · 0001697884-19-000005 |
| At date | 2018-01-31 | 1,874 | USD | 2019-04-26 | 10-K · 0001697884-19-000005 |
| At date | 2017-01-31 | 0 | USD | 2018-05-16 | 10-K · 0001697884-18-000009 |
Related financial histories
- VITASPRING BIOMEDICAL CO., LTD.: total assets
- VITASPRING BIOMEDICAL CO., LTD.: total liabilities
- VITASPRING BIOMEDICAL CO., LTD.: stockholders equity
- VITASPRING BIOMEDICAL CO., LTD.: cash and cash equivalents
- VITASPRING BIOMEDICAL CO., LTD.: net income or loss
- VITASPRING BIOMEDICAL CO., LTD.: operating cash flow
- VITASPRING BIOMEDICAL CO., LTD.: revenue
- VITASPRING BIOMEDICAL CO., LTD.: financing cash flow
- VITASPRING BIOMEDICAL CO., LTD.: investing cash flow
- VITASPRING BIOMEDICAL CO., LTD.: retained earnings or deficit
- VITASPRING BIOMEDICAL CO., LTD.: diluted weighted-average shares
- VITASPRING BIOMEDICAL CO., LTD.: diluted earnings per share
- VITASPRING BIOMEDICAL CO., LTD.: income tax expense or benefit
- VITASPRING BIOMEDICAL CO., LTD.: share-based compensation expense
- VITASPRING BIOMEDICAL CO., LTD.: operating income or loss
- VITASPRING BIOMEDICAL CO., LTD.: current assets
- VITASPRING BIOMEDICAL CO., LTD.: current liabilities
- VITASPRING BIOMEDICAL CO., LTD.: current accounts payable
- VITASPRING BIOMEDICAL CO., LTD.: net current accounts receivable
- VITASPRING BIOMEDICAL CO., LTD.: operating expenses
- VITASPRING BIOMEDICAL CO., LTD.: net inventory
- VITASPRING BIOMEDICAL CO., LTD.: gross profit
- VITASPRING BIOMEDICAL CO., LTD.: selling, general and administrative expense
Inspect the source
- Entity
- VITASPRING BIOMEDICAL CO., LTD. / CIK 0001697884
- Captured
- 2026-09-21T17:23:44.772Z
- SEC response SHA-256
ee15de6dda3aedafc6c6b7ee7d9d21edb5e0091bf01dcbaec55b3fe460e6f43a
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001697884.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))